
CANCELED
In light of the recent COVID-19 developments, and specifically, extended stay-at-home orders and restrictions on mass gatherings in Nashville, NPACE has made the difficult but necessary decision to cancel the NPACE Primary Care and Pharmacology Update Conferences in Nashville (August 27-30). Those registered for the conference were notified by email on June 29th and provided with details on registration refunds and guidance on canceling hotel and travel arrangements. Please continue to monitor your email, the NPACE web site, and our social media channels for the latest details. Any questions please email us at npace@npace.org
Stay safe!
Nashville, TN Conference
2-day Primary Care + 2-day Pharmacology
August 27-30, 2020
Omni Nashville Hotel
22 CONTACT HOURS | 12+ PHARMACOLOGY HOURS
Overview
Fulfill your professional development and specific licensure needs at these 2-day Primary Care and 2-day Pharmacotherapeutics continuing education conferences. Nashville TN Conference sessions emphasize the latest evidence and guideline-based clinical knowledge needed to prescribe and manage high priority primary care topics.
Primary Care (August 27-28) | 10 Contact Hours/(TBA Pharm Hours)
Pharmacology (August 29-30) | 12 Contact Hours/12 Pharm Hours
CONFERENCE REGISTRATION DEADLINES/FEES
Early registration – by July 23, 2020
General Attendee: $355 (one conference) I $680 (both conferences)
Senior (60+), Student/New Grad: $315 (one conference) I $635 (both conferences)
Standard Registration (all types except Military) – after July 23, 2020
$420 (one conference) I $800 (both conferences)
Military – (anytime)
$295 (one conference) I $585 (both conferences)
All registrations are subject to a $50 non-refundable administration fee.
See all NPACE events
Speakers


In 2016, Dr. Baldridge received the Nurse Practitioner Excellence Award for the State of Louisiana and in 2017 became a Fellow of the American Association of Nurse Practitioners. She is the current president of the Louisiana Association of Nurse Practitioners. She is an accomplished author, speaker, and educator. Throughout, her career she has specialized in family practice, urgent care and neurology services. She was the Program Coordinator of Neurology Services in a long-term care facility for people with intellectual and developmental disabilities for over 8 years.
Dr. Baldridge remains in clinical practice in a primary and urgent care setting for the indigent population. She is actively involved in her community and church, providing health care education, outreach and screenings.


She is also the owner of Sapient Health Services, PLLC a consulting service licensed in Virginia and North Carolina specializing in genetic testing services for hereditary cancer syndromes and pharmacogenomic testing. She received a diploma RN at Norfolk General Hospital School of Professional Nursing in 1979, a BS in Nursing with a Minor in Psychology at UNC-Greensboro in 1983 and her MS in Nursing Administration also at UNC-G in 1988. She earned two post-masters certificates at Duke, Nursing Informatics in 1997 and Adult Nurse Practitioner with a focus in Primary Care and Oncology in 2005.
Phyllis has published, and her original research has been presented in poster presentations at the national level. Phyllis was president of the Virginia Council of Nurse Practitioners(VCNP) from 2012-2014 and was awarded the Distinguished NP Award at the VCNP annual meeting in March 2016.

Alison’s nursing practice is based in Massachusetts. Alison has practiced at the South Boston Community Health Center since 2005. She is a full-time Clinical Instructor at the Boston College Connell School of Nursing. Alison is Faculty at The Sylvie Ratelle STD/HIV Prevention Center of New England, a Centers for Disease Control (CDC) funded national training organization for practicing providers. She engages in clinical research regarding sexually transmitted diseases (STDs) and lectures to practicing clinicians nationally and internationally about the identification, treatment, and prevention of STDs.



Chair, Department of Family Medicine, Program Director, Family Medicine Residency, Abington – Jefferson Health, Abington, PA

She received her Bachelor of Science Degree in Nursing from the University of New Hampshire (1991), graduating Magna Cum Laude. She completed her Master of Science Degree in Nursing from Rivier University (2002), graduating with High Distinction. She achieved certification as a Clinical Lipid Specialist (2011), currently a Diplomat of the Accreditation Council for Clinical Lipidology (ACCL). In 2018 she received the designation of Associate of The American College of Cardiology (AACC).
She currently holds memberships with The National Lipid Association (NLA), New Hampshire Nurse Practitioner Association (NHNPA), American College of Cardiology (ACC) and holds certification with The American Nurses Credentialing Center (ANCC). She was named as NH’s Nurse Practitioner of the Year (2010), thereafter receiving NH’s State Excellence Award from The American Academy of Nurse Practitioners (2011). She currently lives in Bedford, NH with her husband John.

Agenda
Thursday, August 27, 2020
Registration
Primary Care Conference
Family care clinicians are the first line of defense for patients suffering from IBS, a common disorder that causes substantial reduction in health-related quality of life. The diagnosis of IBS, whether it is IBS-D, IBS-M, or IBS-C, is generally made clinically, which is impacted by recent changes in the Rome criteria. Now recognized as both a brain-gut and a gut-brain disorder, the treatment of patients with IBS has evolved significantly in the past year. Understanding the patient burden of disease, particularly symptoms that are most troublesome, is helpful in individualizing therapy. The 2018 American College of Gastroenterology IBS guidelines lend clarity to treatments found effective, including soluble fiber and several medications, while finding little evidence to support the use of therapies such as a gluten-free diet, prebiotics/probiotics/synbiotics, and antispasmodics.
Presentation presented by the Primary Care Education Consortium (PCEC). You will receive a certificate of participation for this activity. ANCC accepts AAFP Prescribed credit. and AMA PRA Category 1 Credits. Grant funded by Salix Pharmaceuticals, Inc.
Speakers:
This session is provided by a commercial interest. Contact Hours will not be awarded.
The management of patients with T2DM has undergone a seismic shift from a glucose- centric to a patient-centric focus with a primary goal of reducing cardiovascular risk. The shift to focus on cardiovascular risk stems not only from the fact that microvascular and macrovascular complications continue to be common in persons with type 2 diabetes mellitus, but also from evolving evidence clearly demonstrating cardiovascular risk reduction with some antidiabetic medications. To reduce the burden of disease and improve the journey of persons with type 2 diabetes, however, requires understanding the evidence base for these benefits and differences among the antidiabetic medications, and how treatment can be individualized to address the unmet needs of each patient.
Presentation presented by the Primary Care Education Consortium (PCEC). You will receive a certificate of participation for this activity. ANCC accepts AAFP Prescribed credit. and AMA PRA Category 1 Credits. Grant funded by Lilly.
Speakers:
Friday, August 28, 2020
Primary Care Conference
The pharmacologic treatment of diabetic kidney disease (DKD) has typically involved treatment of associated risk factors such as blood glucose, blood pressure, and the use of medications that act on the renin-angiotensin-aldosterone system. Recently, a variety of glucose-lowering medications have been investigated to assess their potential for improved renal outcomes in patients with type 2 diabetes mellitus and with/without established DKD. Several of these medications have been shown to improve renal outcomes in patients with type 2 diabetes mellitus. This presentation seeks to provide insight into the results of these clinical trials and how the selected medications can be used to individualize therapy as recommended in updated guidelines issued by the American Diabetes Association and the American Association of Clinical Endocrinologists/ American College of Endocrinology.
Presentation presented by the Primary Care Education Consortium (PCEC). You will receive a certificate of participation for this activity. ANCC accepts AAFP Prescribed credit and AMA PRA Category 1 Credits. Sponsored by PCEC and PCMG Supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc
Speakers:
Speakers:
This session is provided by a commercial interest. Contact Hours will not be awarded.
Saturday, August 29, 2020
Registration
Pharmacology Conference
Speakers:
This session is provided by a commercial interest. Contact Hours will not be awarded.
Sunday, August 30, 2020
Pharmacology Conference
By completing this session, participants will be able to apply new evidence into practice regarding the use of diagnostic testing, treatment and chemoprophylaxis for people with, or at risk for, influenza. Also, Incorporate the use of antiviral agents into practice based on their ability to reduce transmission, as well as treat people with influenza who are at normal or high risk for complications.
This activity is supported by an educational grant from Genentech, Inc. This continuing nurse education activity is provided by Vindico Medical Education.
Speakers:
Fee
BOTH CONFERENCES: 2-DAY PRIMARY CARE + 2-DAY PHARMACOLOGY
General Attendee $800.00
$680.00
Thursday, July 23, 2020
Senior (60+) /Student/New Grad $800.00
$635.00
Thursday, July 23, 2020
Military $585.00
PRIMARY CARE ONLY (2 DAYS)
General Attendee $420.00
$355.00
Thursday, July 23, 2020
Senior (60+)/Student/New Grad $420.00
$315.00
Thursday, July 23, 2020
Military $295.00
PHARMACOLOGY ONLY (2 DAYS)
General Attendee $420.00
$355.00
Thursday, July 23, 2020
Senior (60+)/Student/New Grad $420.00
$315.00
Thursday, July 23, 2020
Miltary $295.00
REFUND AND CANCELLATION POLICY
FEES:
All registrations must be paid in full by credit card (Visa, MasterCard, American Express and Discover) at the time of registration. NPACE no longer accepts payment by check. 4th for Free, Letter of Credit and complimentary registrations all require a $50 non-refundable administration fee upon registration.
If using Letter of Credit, 4th for free, or complimentary registration, please contact NPACE 508-907-6424 x1 for registration information.
CANCELLATION BY REGISTRANT:
Written notice of cancellation must be received by email or letter. A refund, excluding the $50 non-refundable administrative fee, will be issued when cancellation is received no later than one month prior to the conference start date. Refunds are processed based on the original form of payment.
A letter of credit, excluding the $50 non-refundable administrative fee, will be issued when cancellation is received between 30 and 8 days of the conference start date. This is valid for 12 months from issuance and may be used for towards any NPACE conference.
No refunds will be issued for cancellations received within 7 days of the conference start date.
CANCELLATION OF EVENT:
In the very unlikely event that NPACE cancels or postpones a conference due to circumstances beyond its control, NPACE’s liability shall be limited to refund of paid registration fees.
HOTEL
HOTEL INFORMATION
Omni Nashville 250 5th Avenue South Nashville, TN 37203 |
|
Cut Off Date: | August 4, 2020 (5:00pm local time) |
Discounted Rate: | $246.00 (plus local/state taxes) |
Resort Fee: | Waived |
Online Reservations: | CLICK HERE FOR RESERVATIONS |
Based on availability; Group rates can apply 3 days before and after the conference dates |
Other Information
Complimentary WIFI in guestrooms
Complimentary fitness center access
$3.00 Discount on published valet parking rates
NPACE Room Block Note
NPACE strongly advises that you do not make travel reservations until you have a confirmed conference registration. NPACE conferences frequently sell out prior to early registration date.
Hotel Rates are based on room block availability and can’t be guaranteed if room block sells out before cut off dates. Space and room types are limited, so please make your reservations early! Hotel cancellation policies vary, check with hotel for cancellation policy if you need to cancel your reservation. Only reservations made through the group block are eligible for additional amenities and discounts.
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|
Abstract Submission
Abstract submission is now closed. Thank you to everyone for their submissions.
NPACE is currently accepting poster abstracts for our 2020 conference in Nashville, TN. Research should be focused on health policy, innovation, evidence based clinical practice, scientific research, or collaboration and interdisciplinary practice. Sub-topic ideas should include primary care, mental health, pediatrics, geriatrics, or palliative- end of life care. Submission is open to students and faculty from MSN, DNP, and PhD programs.
Simply complete the Abstract Submission Form below to submit your abstract for review.
KEY DATES:
June 15, 2020 | Online submission of abstracts close |
June 22, 2020 | Email notification sent to all submissions |
July 1, 2020 | Deadline to return completed Presenter Agreement |
July 10, 2020 | Deadline to register for conference |
GUIDELINES FOR POSTER ABSTRACT
- Full name of submitting/corresponding author and all co-authors
- Abstract text:
- Use Times New Roman, 12 Font, 1-inch margins
- Limit to 300 words excluding title, authors info (affiliations) and references
- Highlight the main points:
- Introduction: Info statement with purpose of the presentation
- Methods: Brief description of the research-background
- Discussion: Summary of the unpublished data or other relevant info
- Conclusion: Summarize in 1 or 2 sentences the primary outcomes of the study, including their potential significance
- Funding sources: Funding sources (organizations, institutions, agencies) for the research included in the abstract should be listed.
- Must not contain any commercial bias
SUBMISSION REQUIREMENTS
- Resume(s) for author(s)
- Short bio statements for all poster authors
- One measurable learning outcome.
- 50-word presentation summary that will be used for conference publication
- Entire poster must fit onto a 3-foot x 4-foot board
- Co-authors submitted with the accepted abstracts will be included in the conference materials.
- Decisions on abstract acceptance are final.
ATTENDANCE REQUIRED
Accepted abstracts must have a presenter in attendance during conference session breaks on August 27, 2020 to present their poster(s).
It is not mandatory that the first author be pre-registered and present; the presenter may be any of the contributing authors or a colleague.
CONFERENCE REGISTRATION FEE
Author associated with an abstract must register for the conference and are responsible for all travel expenses (airfare, hotel, etc.) associated with presenting at the meeting. The conference registration is separate from the abstract submission. Abstracts will be removed from the conference if author(s) are not registered for the conference by May 22, 2020. If a presenter(s) withdraws from the conference the poster submission will be removed.
Note our Faculty Program: We recognize the important role of academic faculty in preparing the next generation of NP leaders, and as a show of support, we offer one free conference registration per 24-month period to full-time faculty of NP academic programs. A limited number of seats are put aside at each conference for faculty taking advantage of this NPACE Perk.
ABSTRACT REVIEW
All abstracts will be reviewed and selected based on criteria requirements by an NPACE nurse planner. This will ensure adherence to ANCC Commission on Accreditation CE provider guidelines.
AUTHORS’ AGREEMENT
Upon acceptance of an abstract, presenters will receive a presenter agreement with dates and guidelines. This agreement will need to be signed and returned to NPACE within one week of receipt of email notification of poster acceptance. Failure to return agreement will result in removal of the abstract from the presentation.
ELECTRONIC EPOSTERS
Upon acceptance of an abstract, presenters will receive information pertaining to the NPACE ePoster learning toolbox. These ePosters are web-based allowing presenters to quickly and easily build a virtual ePoster using stacks of interactive blocks containing vital information including text, graphics, links to video and other websites. Presenter will be also asked to provide 5 multiple choice questions/answers for NPACE to create a google quiz that will be incorporated into your ePoster. This will allow learners to earn contacts hours for viewing the ePoster and completing the online quiz. By utilizing this ePoster system, NPACE will house your poster in its online library for other medical professions to view in the future.